Novos strategy is simple: build on what works
doi: 10.4103/jomfp.JOMFP_207_20
Participants with confirmed liver disease showed substantial reductions in liver fat content and, importantly, improvements in liver inflammation and fibrosis markers
However, the appetite-suppression benefit stops immediately, making relapse significantly more likely without ongoing treatment
At En Vogue IV Therapy & Wellness Clinic, we treat a large number of patients suffering from type 2 diabetes and obesity, two illnesses that frequently coexist and exacerbate one another
In patients with a suggestive clinical presentation, but not fully compatible with established diagnostic criteria, DEXA may help distinguish lipedema from obesity by objectively quantifying regional fat distribution